• Company
• KRW 40 bil JAKi market is in a fierce three-way race
• by Kim, Jin-Gu Feb 7, 2024 05:59am

• Company
• Colorectal cancer drug Fruzaqla gets Orphan Drug Designation
• by Eo, Yun-Ho Feb 7, 2024 05:59am

• Policy
• HIRA 'Ease entry of new drugs and strengthen post-evals'
• by Lee, Tak-Sun Feb 7, 2024 05:59am

• Company
• Oral ulcerative colitis drug Zeposia is actively prescribed
• by Eo, Yun-Ho Feb 6, 2024 06:10am

• Opinion
• [Reporter’s View] Handling AI-collected ‘cancer info’
• by Kim, Jin-Gu Feb 6, 2024 06:10am

• Opinion
• [Desk’s View] New principles rouse moral responsibility
• by Lee, Tak-Sun Feb 6, 2024 06:10am

• Policy
• Bill for consigned manufacture of advanced biologics
• by Lee, Jeong-Hwan Feb 6, 2024 06:10am

• Opinion
• [Reporter’s View] Restructuring in pharmaceutical industry
• by Son, Hyung-Min Feb 5, 2024 07:27pm

• Company
• Growth hormone Ngenla can be prescribed in general hospitals
• by Eo, Yun-Ho Feb 5, 2024 05:54am

• Product
• Forxiga return policy in question amid AZ-Daewoong dispute
• by Kang, Hye-Kyung Feb 5, 2024 05:54am